Contineum Therapeutics, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2022 | — | $-93.2M | — |
| FY2023 | — | $-67.9M | $15.5M |
| FY2024 | — | $198.1M | $21.9M |
| FY2025 | — | $261.0M | $75.6M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2022 | — | $-93.2M | — |
| FY2023 | — | $-67.9M | $15.5M |
| FY2024 | — | $198.1M | $21.9M |
| FY2025 | — | $261.0M | $75.6M |